600369 西南证券
交易中 04-25 09:53:43
资讯
新帖
简况
北向资金4月24日净卖出西南证券35.36万股 连续5日减持
自选股智能写手 · 24分钟前
北向资金4月24日净卖出西南证券35.36万股 连续5日减持
西南证券:给予科博达买入评级
证券之星 · 04-24 20:20
西南证券:给予科博达买入评级
西南证券:给予金徽酒买入评级
证券之星 · 04-24 20:20
西南证券:给予金徽酒买入评级
西南证券:给予天佑德酒买入评级
证券之星 · 04-24 19:20
西南证券:给予天佑德酒买入评级
西南证券:给予长安汽车买入评级
证券之星 · 04-24 19:01
西南证券:给予长安汽车买入评级
西南证券:给予东鹏饮料买入评级
证券之星 · 04-24 16:37
西南证券:给予东鹏饮料买入评级
西南证券:给予海思科买入评级
证券之星 · 04-24 16:37
西南证券:给予海思科买入评级
川环科技涨5.16%,西南证券二个月前给出“买入”评级
证券之星 · 04-24 16:19
川环科技涨5.16%,西南证券二个月前给出“买入”评级
新国都涨5.27%,西南证券二周前给出“买入”评级
证券之星 · 04-24 16:17
新国都涨5.27%,西南证券二周前给出“买入”评级
券商概念盘中跳水,西南证券平盘
自选股智能写手 · 04-24 14:08
券商概念盘中跳水,西南证券平盘
西南证券:给予百克生物买入评级
证券之星 · 04-23 18:01
西南证券:给予百克生物买入评级
西南证券:给予长春高新买入评级
证券之星 · 04-23 16:52
西南证券:给予长春高新买入评级
西南证券:给予长虹美菱买入评级
证券之星 · 04-23 16:51
西南证券:给予长虹美菱买入评级
西南证券:给予华辰装备增持评级
证券之星 · 04-23 16:51
西南证券:给予华辰装备增持评级
西南证券:给予川环科技买入评级
证券之星 · 04-23 16:51
西南证券:给予川环科技买入评级
西南证券:给予佐力药业买入评级
证券之星 · 04-23 16:50
西南证券:给予佐力药业买入评级
海创药业-U涨5.84%,西南证券一周前给出“买入”评级
证券之星 · 04-23 16:26
海创药业-U涨5.84%,西南证券一周前给出“买入”评级
新点软件获西南证券买入评级,下游需求扰动,积极探索AI+数据要素新机遇
金融界 · 04-23 16:14
新点软件获西南证券买入评级,下游需求扰动,积极探索AI+数据要素新机遇
西南证券给予国盛智科持有评级,2023年业绩承压,期待需求回暖
每日经济新闻 · 04-23 12:22
西南证券给予国盛智科持有评级,2023年业绩承压,期待需求回暖
西南证券给予信捷电气持有评级,2023年年报点评:伺服毛利率趋稳向上,变频、步进贡献新增量
每日经济新闻 · 04-23 10:56
西南证券给予信捷电气持有评级,2023年年报点评:伺服毛利率趋稳向上,变频、步进贡献新增量
加载更多
公司概况
公司名称:
西南证券股份有限公司
所属行业:
资本市场服务
上市日期:
2001-01-09
主营业务:
西南证券股份有限公司主营业务为证券及期货经纪业务、投资银行业务、自营业务、资产管理业务等。主要服务包括证券经纪业务、投资银行业务、证券自营业务、资产管理业务。公司拥有全牌照业务资格且综合业务平台逐步发力,能为客户提供全方位服务。
发行价格:
6.18
{"stockData":{"symbol":"600369","market":"SH","secType":"STK","nameCN":"西南证券","latestPrice":3.73,"timestamp":1714010023000,"preClose":3.76,"halted":0,"volume":3786900,"delay":0,"floatShares":6315000000,"shares":6645000000,"eps":0.1347,"marketStatus":"交易中","marketStatusCode":2,"change":-0.03,"latestTime":"04-25 09:53:43","open":3.74,"high":3.76,"low":3.72,"amount":14131700,"amplitude":0.0106,"askPrice":3.73,"askSize":6119,"bidPrice":3.72,"bidSize":9485,"shortable":0,"etf":0,"ttmEps":0.1347,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1714015800000},"adr":0,"adjPreClose":3.76,"symbolType":"stock","openAndCloseTimeList":[[1714008600000,1714015800000],[1714021200000,1714028400000]],"highLimit":4.14,"lowLimit":3.38,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":6645109124,"pbRate":0.98,"roa":"--","roe":"2.39%","epsLYR":0.09,"committee":-0.230392,"marketValue":24786000000,"floatMarketCap":23555000000,"peRate":27.691165,"changeRate":-0.008,"turnoverRate":0.0006,"status":1},"requestUrl":"/m/hq/s/600369","defaultTab":"news","newsList":[{"id":"2430411207","title":"北向资金4月24日净卖出西南证券35.36万股 连续5日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2430411207","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430411207?lang=zh_cn&edition=full","pubTime":"2024-04-25 09:30","pubTimestamp":1714008611,"startTime":"0","endTime":"0","summary":"4月24日,北向资金减持西南证券35.36万股连续5日减持。截止当日收盘,沪股通共持有西南证券6573.66万股,占流通股1.04%。沪股通减持金额前五个股分别为兆易创新、中微公司、金山办公、江苏银行、国电南瑞。西南证券近5个交易日下跌0.27%,沪股通累计减持352.11万股;近20个交易日下跌2.84%,沪股通累计减持357.51万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042509313587acecbd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042509313587acecbd&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429430217","title":"西南证券:给予科博达买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2429430217","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429430217?lang=zh_cn&edition=full","pubTime":"2024-04-24 20:20","pubTimestamp":1713961253,"startTime":"0","endTime":"0","summary":"西南证券股份有限公司郑连声近期对科博达进行研究并发布了研究报告《Q1业绩超预期,新产品新客户逐渐放量》,本报告对科博达给出买入评级,当前股价为69.61元。预计公司2024-2026年EPS分别为2.17/2.69/3.31元,对应PE为31/25/20倍,归母净利润CAGR为30%,维持“买入”评级。最新盈利预测明细如下:该股最近90天内共有15家机构给出评级,买入评级12家,增持评级3家;过去90天内机构目标均价为86.49。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042400043192.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429430265","title":"西南证券:给予金徽酒买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2429430265","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429430265?lang=zh_cn&edition=full","pubTime":"2024-04-24 20:20","pubTimestamp":1713961252,"startTime":"0","endTime":"0","summary":"西南证券股份有限公司朱会振,王书龙近期对金徽酒进行研究并发布了研究报告《2024年一季报点评:省内夯实省外拓展,经营势能持续释放》,本报告对金徽酒给出买入评级,当前股价为21.57元。公司持续受益全国化布局和消费升级红利,看好公司长期成长能力,维持“买入”评级。最新盈利预测明细如下:该股最近90天内共有32家机构给出评级,买入评级22家,增持评级10家;过去90天内机构目标均价为26.26。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042400043189.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429310614","title":"西南证券:给予天佑德酒买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2429310614","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429310614?lang=zh_cn&edition=full","pubTime":"2024-04-24 19:20","pubTimestamp":1713957654,"startTime":"0","endTime":"0","summary":"西南证券股份有限公司朱会振,王书龙近期对天佑德酒进行研究并发布了研究报告《高增势能延续,业绩弹性十足》,本报告对天佑德酒给出买入评级,当前股价为10.9元。公司受益于省内消费升级和省外市场开拓,看好公司长期成长能力,维持“买入”评级。最新盈利预测明细如下:该股最近90天内共有2家机构给出评级,买入评级1家,增持评级1家。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042400040198.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429439181","title":"西南证券:给予长安汽车买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2429439181","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429439181?lang=zh_cn&edition=full","pubTime":"2024-04-24 19:01","pubTimestamp":1713956488,"startTime":"0","endTime":"0","summary":"西南证券股份有限公司郑连声近期对长安汽车进行研究并发布了研究报告《2023年年报点评:新能源转型加快,全球化持续推进》,本报告对长安汽车给出买入评级,当前股价为16.29元。公司24年规划目标清晰,新车持续落地,看好全年加速成长,维持“买入”评级。最新盈利预测明细如下:该股最近90天内共有25家机构给出评级,买入评级21家,增持评级4家;过去90天内机构目标均价为23.09。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042400039237.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429018481","title":"西南证券:给予东鹏饮料买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2429018481","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429018481?lang=zh_cn&edition=full","pubTime":"2024-04-24 16:37","pubTimestamp":1713947832,"startTime":"0","endTime":"0","summary":"西南证券股份有限公司朱会振,夏霁近期对东鹏饮料进行研究并发布了研究报告《2024年一季报点评:新品表现强劲,延续高增长》,本报告对东鹏饮料给出买入评级,当前股价为197.88元。最新盈利预测明细如下:该股最近90天内共有39家机构给出评级,买入评级30家,增持评级9家;过去90天内机构目标均价为223.38。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042400033324.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429481792","title":"西南证券:给予海思科买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2429481792","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429481792?lang=zh_cn&edition=full","pubTime":"2024-04-24 16:37","pubTimestamp":1713947826,"startTime":"0","endTime":"0","summary":"西南证券股份有限公司杜向阳近期对海思科进行研究并发布了研究报告《HSK16149获批在即,环泊酚出海可期》,本报告对海思科给出买入评级,当前股价为27.28元。 HSK16149胶囊有望2024Q2获批上市。 HSK21542注射液上市申请获受理,口服剂型进入二期临床。预计公司2024-2026年归母净利润为4.1亿元、5.7亿元和7.7亿元,对应PE分别为71倍、51倍和38倍,维持“买入”评级。最新盈利预测明细如下:该股最近90天内共有4家机构给出评级,买入评级3家,增持评级1家。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042400033320.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429489144","title":"川环科技涨5.16%,西南证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2429489144","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429489144?lang=zh_cn&edition=full","pubTime":"2024-04-24 16:19","pubTimestamp":1713946743,"startTime":"0","endTime":"0","summary":"今日川环科技涨5.16%,收盘报18.35元。2024年1月31日,西南证券研究员郑连声发布了对川环科技的研报《Q4业绩好于预期,经营效率持续提升》,该研报对川环科技给出“买入”评级。研报中预计公司23-25年EPS为0.76/1.07/1.42元,对应PE为19/14/10倍,归母净利润CAGR为36.2%,维持“买入”评级。证券之星数据中心计算显示,对该股盈利预测较准的分析师团队为海通证券的房乔华、刘一鸣。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042400032089.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429489179","title":"新国都涨5.27%,西南证券二周前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2429489179","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429489179?lang=zh_cn&edition=full","pubTime":"2024-04-24 16:17","pubTimestamp":1713946675,"startTime":"0","endTime":"0","summary":"今日新国都涨5.27%,收盘报21.96元。2024年4月9日,西南证券研究员王湘杰,邓文鑫发布了对新国都的研报《业绩高速增长,海外布局完善》,该研报对新国都给出“买入”评级。证券之星数据中心根据近三年发布的研报数据计算,该研报作者对此股的盈利预测准确度为79.72%。证券之星数据中心计算显示,对该股盈利预测较准的分析师团队为西南证券的邓文鑫。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042400032031.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429046661","title":"券商概念盘中跳水,西南证券平盘","url":"https://stock-news.laohu8.com/highlight/detail?id=2429046661","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429046661?lang=zh_cn&edition=full","pubTime":"2024-04-24 14:08","pubTimestamp":1713938887,"startTime":"0","endTime":"0","summary":"04月24日,券商概念盘中跳水,截至14点08分,券商概念整体指数下跌0.62%,报1498.080点。从个股上来看,该概念的成分股中,西南证券平盘,东北证券跌幅居前。从资金上来看,截止发稿,券商概念主力净流入为-5.38亿,其中方正证券受到资金热捧,主力净流入5429.86万;拉长时间线来看,该板块近20日主力资金净流入-194.12亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042414080787e831c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042414080787e831c8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429004161","title":"西南证券:给予百克生物买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2429004161","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429004161?lang=zh_cn&edition=full","pubTime":"2024-04-23 18:01","pubTimestamp":1713866501,"startTime":"0","endTime":"0","summary":"西南证券股份有限公司杜向阳,张殊豪近期对百克生物进行研究并发布了研究报告《2024年一季报点评:带状疱疹疫苗发货季度波动,全年放量可期》,本报告对百克生物给出买入评级,当前股价为40.26元。公司一季度带状疱疹疫苗发货环比下降主要系Q1春节放假的季度间波动所致。最新盈利预测明细如下:该股最近90天内共有12家机构给出评级,买入评级11家,增持评级1家;过去90天内机构目标均价为61.39。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042300035424.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429916531","title":"西南证券:给予长春高新买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2429916531","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429916531?lang=zh_cn&edition=full","pubTime":"2024-04-23 16:52","pubTimestamp":1713862349,"startTime":"0","endTime":"0","summary":"西南证券股份有限公司杜向阳,张殊豪近期对长春高新进行研究并发布了研究报告《2024年一季报点评:长效生长激素占比提升,在研管线持续兑现》,本报告对长春高新给出买入评级,当前股价为110.9元。根据公司最新投资者关系活动记录表,带状疱疹疫苗已经在全国30个省、自治区、直辖市完成准入。维持“买入”评级。最新盈利预测明细如下:该股最近90天内共有15家机构给出评级,买入评级14家,增持评级1家;过去90天内机构目标均价为184.37。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042300031369.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429816314","title":"西南证券:给予长虹美菱买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2429816314","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429816314?lang=zh_cn&edition=full","pubTime":"2024-04-23 16:51","pubTimestamp":1713862296,"startTime":"0","endTime":"0","summary":"西南证券股份有限公司龚梦泓近期对长虹美菱进行研究并发布了研究报告《2024年一季报点评:收入增速环比提升,盈利能力保持稳健》,本报告对长虹美菱给出买入评级,当前股价为9.21元。 毛利率下降,费用率控制良好实现净利率提升。预计公司2024-2026年EPS分别为0.87元、1.03元、1.14元,维持“买入”评级。最新盈利预测明细如下:该股最近90天内共有7家机构给出评级,买入评级6家,增持评级1家。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042300031341.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429631371","title":"西南证券:给予华辰装备增持评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2429631371","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429631371?lang=zh_cn&edition=full","pubTime":"2024-04-23 16:51","pubTimestamp":1713862287,"startTime":"0","endTime":"0","summary":"西南证券股份有限公司邰桂龙,王宁近期对华辰装备进行研究并发布了研究报告《轧辊磨床龙头,高端磨床新星》,本报告对华辰装备给出增持评级,当前股价为22.25元。 全年期间费用率保持稳定,净利率同比明显提升。预计公司 2024-2026年归母净利润分别为 1.5、 1.7、 2.1亿元,未来三年归母净利润复合增长率为 21%,首次覆盖给予“持有”评级。最新盈利预测明细如下:该股最近90天内共有4家机构给出评级,增持评级4家。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042300031336.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429163117","title":"西南证券:给予川环科技买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2429163117","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429163117?lang=zh_cn&edition=full","pubTime":"2024-04-23 16:51","pubTimestamp":1713862269,"startTime":"0","endTime":"0","summary":"西南证券股份有限公司近期对川环科技进行研究并发布了研究报告《业绩符合预期,客户持续开拓》,本报告对川环科技给出买入评级,当前股价为17.45元。预计公司2024-2026年EPS分别为1.01/1.23/1.43元,对应PE为17/14/12倍,归母净利润CAGR为24.1%,维持“买入”评级。最新盈利预测明细如下:该股最近90天内共有3家机构给出评级,买入评级2家,增持评级1家;过去90天内机构目标均价为21.8。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042300031325.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429165392","title":"西南证券:给予佐力药业买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2429165392","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429165392?lang=zh_cn&edition=full","pubTime":"2024-04-23 16:50","pubTimestamp":1713862248,"startTime":"0","endTime":"0","summary":"西南证券股份有限公司杜向阳近期对佐力药业进行研究并发布了研究报告《2024Q1业绩超预期,乌灵胶囊增速亮眼》,本报告对佐力药业给出买入评级,当前股价为14.52元。 佐力药业 事件:公司发布2023年年报及2024年一季报。预计2024-2026年归母净利润分别为5.2亿元、6.3亿元、7.7亿元,对应同比增速分别为37%/21%/21%,维持“买入”评级。最新盈利预测明细如下:该股最近90天内共有8家机构给出评级,买入评级7家,增持评级1家;过去90天内机构目标均价为18.25。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042300031298.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429150735","title":"海创药业-U涨5.84%,西南证券一周前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2429150735","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429150735?lang=zh_cn&edition=full","pubTime":"2024-04-23 16:26","pubTimestamp":1713860797,"startTime":"0","endTime":"0","summary":"今日海创药业-U涨5.84%,收盘报26.47元。2024年4月15日,西南证券研究员杜向阳发布了对海创药业的研报《2023年报点评:氘恩扎卢胺有望2024年底获批上市》,该研报对海创药业给出“买入”评级。研报中预计公司2024-2026年实现营业收入分别约为0.1、1.6、3.8亿元。考虑海创药业研发实力强劲,氘代和PROTAC技术平台实力出众,首款创新药德恩鲁胺NDA已获受理,维持“买入”评级。证券之星数据中心计算显示,对该股盈利预测较准的分析师团队为财通证券的华挺。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042300029729.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429150058","title":"新点软件获西南证券买入评级,下游需求扰动,积极探索AI+数据要素新机遇","url":"https://stock-news.laohu8.com/highlight/detail?id=2429150058","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2429150058?lang=zh_cn&edition=full","pubTime":"2024-04-23 16:14","pubTimestamp":1713860065,"startTime":"0","endTime":"0","summary":"4月23日,新点软件获西南证券买入评级,近一个月新点软件获得2份研报关注。研报认为,新点软件正在积极探索AI、大数据等领域,开发行业大模型和智能Agent框架,并将大模型技术与公司业务场景相结合,在政务服务数字人、智能公文等领域进行验证和落地应用。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404231614308b49af6f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404231614308b49af6f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429132648","title":"西南证券给予国盛智科持有评级,2023年业绩承压,期待需求回暖","url":"https://stock-news.laohu8.com/highlight/detail?id=2429132648","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2429132648?lang=zh_cn&edition=full","pubTime":"2024-04-23 12:22","pubTimestamp":1713846121,"startTime":"0","endTime":"0","summary":"西南证券04月23日发布研报称,给予国盛智科(688558.SH,最新价:19.95元)持有评级。评级理由主要包括:1)下游装备投资乏力,营收有所下降;行业竞争加剧,毛利率降低;2)规模效应下降,全年期间费用率小幅提升,净利率小幅降低;3)国内市场高端机床自主可控需求旺盛,大规模设备更新政策刺激需求;海外市场拓展空间大。风险提示:宏观经济波动风险、行业竞争加剧风险,原材料价格波动风险。文章来源:每日经济新闻原标题:西南证券给予国盛智科持有评级,2023年业绩承压,期待需求回暖","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042312390687a4374c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042312390687a4374c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429747136","title":"西南证券给予信捷电气持有评级,2023年年报点评:伺服毛利率趋稳向上,变频、步进贡献新增量","url":"https://stock-news.laohu8.com/highlight/detail?id=2429747136","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2429747136?lang=zh_cn&edition=full","pubTime":"2024-04-23 10:56","pubTimestamp":1713841010,"startTime":"0","endTime":"0","summary":"西南证券04月23日发布研报称,给予信捷电气(603416.SH,最新价:27.33元)持有评级。评级理由主要包括:1)盈利能力短期承压,研发投入维持高位;2)伺服毛利率趋稳向上,产品迭代降本增效;3)PLC业务稳定增长,国产替代率有望逐步提升;4)智能装置业务快速起量,毛利率有所提升。风险提示:竞争加剧导致产品价格下降的风险;原材料价格上涨的风险;产品研发不及预期的风险;下游传统行业复苏不及预期的风险。文章来源:每日经济新闻原标题:西南证券给予信捷电气持有评级,2023年年报点评:伺服毛利率趋稳向上,变频、步进贡献新增量","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042311090787a3e361&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042311090787a3e361&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2001-01-09","address":"重庆市江北区金沙门路32号西南证券总部大楼","stockEarnings":[{"period":"1week","weight":-0.0027},{"period":"1month","weight":-0.0284},{"period":"3month","weight":-0.0457},{"period":"6month","weight":-0.0852},{"period":"1year","weight":0.0367},{"period":"ytd","weight":-0.0807}],"companyName":"西南证券股份有限公司","boardCode":"AI0067","perCapita":"45088股","boardName":"资本市场服务","registeredCapital":"664510万元","compareEarnings":[{"period":"1week","weight":-0.0086},{"period":"1month","weight":0.0061},{"period":"3month","weight":0.0477},{"period":"6month","weight":0.009},{"period":"1year","weight":-0.0674},{"period":"ytd","weight":0.0235}],"survey":" 西南证券股份有限公司主营业务为证券及期货经纪业务、投资银行业务、自营业务、资产管理业务等。主要服务包括证券经纪业务、投资银行业务、证券自营业务、资产管理业务。公司拥有全牌照业务资格且综合业务平台逐步发力,能为客户提供全方位服务。","serverTime":1714010029876,"listedPrice":6.18,"stockholders":"140060人(较上一季度增加8.99%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"西南证券(600369)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供西南证券(600369)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"西南证券,600369,西南证券股票,西南证券股票老虎,西南证券股票老虎国际,西南证券行情,西南证券股票行情,西南证券股价,西南证券股市,西南证券股票价格,西南证券股票交易,西南证券股票购买,西南证券股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"西南证券(600369)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供西南证券(600369)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}